[ET Net News Agency, 4 July 2019] Austar Lifesciences Limited (06118) said Austar
Biosciences Germany, an indirect wholly-owned subsidiary of the company, entered into an
investment agreement for the formation of a joint venture in Germany.
The joint venture will be owned by the group as to 51% and become an indirect non-wholly
owned subsidiary of the company to carry out business regarding development, engineering,
production, sale of systems and parts for systems, maintenance and other services for
purified water and highly purified water equipment requested by manufacturers and/or
providers of medicinal drug products and other products and services in the pharmaceutical
and life sciences industries and other customers in the life sciences industries. (RC)